Potential Clinical Use of CytoSorb^® for Ticagrelor and Rivaroxaban Elimination Prior to Emergency Orthopedic Surgery in Trauma Patients

Background: Major orthopedic trauma in patients receiving anticoagulants such as ticagrelor or rivaroxaban poses a significant perioperative challenge, particularly in emergency contexts where bleeding risks are heightened and specific reversal agents may be unavailable. CytoSorb^®, a hemo...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Gabriele Melegari, Fabio Gazzotti, Federica Arturi, Elisabetta Bertellini, Andrea Tognù, Domenico Pietro Santonastaso, Matteo Villani, Francesca Coppi, Fabrizio Fattorini, Fabio Catani, Alberto Barbieri
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-07-01
Schriftenreihe:	Life
Schlagworte:	CytoSorb<sup>®</sup> trauma ticagrelor rivaroxoban removal
Online-Zugang:	https://www.mdpi.com/2075-1729/15/7/1065
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!